Genomics company explores NFTs in hopes of advancing precision medicine
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Why this matters
This nft story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Cantor Fitzgerald nearly triples its stake in Bitcoin treasury company Strategy
Cantor Fitzgerald's increased stake in Strategy highlights growing institutional confidence in Bitcoin, potentially influencing ma...
Michael Saylor says Strategy wants to be the world’s most valuable company, with Bitcoin as the engine
Strategy's aggressive Bitcoin acquisition strategy could significantly influence market dynamics, impacting both investor sentimen...
Wallet tied to Sky founder borrowed $1M days before his company collapsed
A wallet tied to Rune Christensen, the founder of DAI stablecoin protocol Maker and its USDS successor Sky, borrowed $1 million ag...
World Bank Group Explores USDC Payments With Citi
Circle's USDC infrastructure and Citi's banking connections will underpin an exploration of stablecoin-based development-fund paym...
Circle Expands Disparte and Walia Roles as Stablecoin Operations Scale
TL;DR Dante Disparte becomes vice chairman for strategy and global affairs. Mandeep Walia adds chief operating officer to his comp...
Travala Unveils AVA+ Partners, a New Route to Crypto Payments Powered by AVA
Singapore, Singapore, October 29th, 2026, Chainwire Crypto projects will be able to lock AVA to have their token accepted as payme...